Danimer Scientific, Inc.

Danimer Scientific, Inc (NYSE: DNMR) manufactures PHA, which is a fully biodegradable plastic feedstock alternative sold under the proprietary Nodax® brand name, used for a wide variety of plastic applications, including water bottles, straws, food containers, etc.

Key Updates:

• Management Update: Recently, the company declared the joining of Brad Rodgers for the post of Vice President – Technology Development R&D. Earlier, Rodgers has and worked for research and development of new technology solutions, which enhances packaging performance with the major focus of minimizing environmental impacts.
• Impressive Growth prospects: The company’s upcoming operations are likely to be supported by increasing Government’s and Corporate Initiatives to reduce Environmental Impact of Global Pollution Crisis. Moreover, the company has Strategic collaborations with corporate giants like Pepsi and Nestle and Key Converters such as Wincup and Genpak and also received Equity Investment from Pepsi, which shows strong support from industry leaders.
• Event Update: The company reported that it would announce its fourth quarter FY20 financial result on March 29, 2021.

Q3FY20 Financial Highlights:

• DNMR announced its quarterly result, wherein the company posted loss from operations at USD 0.197 million and reported interest earned on marketable securities held in Trust Account of USD 0.045 million.
• Net loss stood at USD 0.152 million during the third quarter of FY20.
• Cash and cash equivalents were reported at USD 1.398 million, while total assets were recorded at USD 201.602 million.

Q3FY20 Income Statement Highlights (Source: Company Report)

Risks: The group’s operations are comparatively new, while the group is yet to report revenue, which is a key concern. Further the entry of a new player might lead to price competition and loss of clients.

Stock Recommendation:

In the recent past, the group witnessed a rapidly Growing Blue Chip Customer Base within Take-or-Pay Contracts, while the company is focusing on expanding its Phase II Capacity Addition, which is a key positive. The Management expect its revenue and EBITDA to grow at a CAGR of ~59% and ~140%, respectively, during FY20 to FY25, driven by strong momentum from the PHA resins segment. The stock of DNMR surged ~176% and ~334% in the last three months and nine months, respectively. Although, the prices have corrected in last one month, still the stock is trading at a higher valuation from the P/E multiple standpoints. The company is trading at an NTM PE ratio of 767.30x, as compared to the industry (Containers and Packaging Materials) median of 13.7x, which implies a significantly stretched valuation. Hence, we recommend an ‘Expensive’ rating on the stock at the closing price of USD 41.84 on March 12, 2021.

1-Year Price Chart (as on March 12, 2021). Source: Refinitiv (Thomson Reuters)

Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine do not hold interests in any of the securities or other financial products covered on the Kalkine website.